AMIDE COMPOUND, ITS PHARMACEUTICAL USE AND NEW 1-SUBSTITUTED PYRROLIDINEMETHYLAMINES

PURPOSE:To obtain a new amide compound useful for treating psychosomatic diseases and phrenopathy. CONSTITUTION:An amide compound expressed by formula I {R is 1-4C alkoxy; R is H or R and R are bonded to form oxyethylene; R is S(O)mR [R is 1-4C alkyl or phenylalkyl; (m) is 0-2] or SO2NR R (R and R a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IKEBE TSUGIO, MURAKAMI OSAMU, MORIMOTO YASUTO, TAKEHARA SHUZO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IKEBE TSUGIO
MURAKAMI OSAMU
MORIMOTO YASUTO
TAKEHARA SHUZO
description PURPOSE:To obtain a new amide compound useful for treating psychosomatic diseases and phrenopathy. CONSTITUTION:An amide compound expressed by formula I {R is 1-4C alkoxy; R is H or R and R are bonded to form oxyethylene; R is S(O)mR [R is 1-4C alkyl or phenylalkyl; (m) is 0-2] or SO2NR R (R and R are H or 1-4C alkyl); R is 6-15C alkyl} and its salt or optical isomer thereof, e.g. (S)-N-[(1- hexyl-2-pyrrolidinyl)methyl]2-methoxy-5-sulfamoylbenzamide. The af orementioned compound is obtained by reacting a carboxylic acid expressed by formula II or its reactive derivative with a 1-substituted pyrrolidine-2- methylamines expressed by formula III. The resultant compound is useful as an antischizophrenic agent, a therapeutic agent for dystropy, emotional disorder, etc., a medicine such as an inhibitor for psychosomatic diseases or emesis, a therapeutic agent for diarrhea originating from stress, tension of feeling, etc., and indefinite complaint of alimentary systems.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH04225954A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH04225954A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH04225954A3</originalsourceid><addsrcrecordid>eNqNzL0KwjAUQOEsDqK-w3W3oLUdOsbkSiL5I7lBOpUicRIt1PdHBx_A6SwfZ8mIWy0RhLfBZyd3oClBUDxaLjCTFtxATgjcSXB4hUOV8imRpkwoIfQxeqOldmiRVG--N4dpzRb38TGXza8rtj0jCVWV6TWUeRpv5VnewyWofVPXbdc2_PiP-QBGJzCo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMIDE COMPOUND, ITS PHARMACEUTICAL USE AND NEW 1-SUBSTITUTED PYRROLIDINEMETHYLAMINES</title><source>esp@cenet</source><creator>IKEBE TSUGIO ; MURAKAMI OSAMU ; MORIMOTO YASUTO ; TAKEHARA SHUZO</creator><creatorcontrib>IKEBE TSUGIO ; MURAKAMI OSAMU ; MORIMOTO YASUTO ; TAKEHARA SHUZO</creatorcontrib><description>PURPOSE:To obtain a new amide compound useful for treating psychosomatic diseases and phrenopathy. CONSTITUTION:An amide compound expressed by formula I {R is 1-4C alkoxy; R is H or R and R are bonded to form oxyethylene; R is S(O)mR [R is 1-4C alkyl or phenylalkyl; (m) is 0-2] or SO2NR R (R and R are H or 1-4C alkyl); R is 6-15C alkyl} and its salt or optical isomer thereof, e.g. (S)-N-[(1- hexyl-2-pyrrolidinyl)methyl]2-methoxy-5-sulfamoylbenzamide. The af orementioned compound is obtained by reacting a carboxylic acid expressed by formula II or its reactive derivative with a 1-substituted pyrrolidine-2- methylamines expressed by formula III. The resultant compound is useful as an antischizophrenic agent, a therapeutic agent for dystropy, emotional disorder, etc., a medicine such as an inhibitor for psychosomatic diseases or emesis, a therapeutic agent for diarrhea originating from stress, tension of feeling, etc., and indefinite complaint of alimentary systems.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1992</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19920814&amp;DB=EPODOC&amp;CC=JP&amp;NR=H04225954A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19920814&amp;DB=EPODOC&amp;CC=JP&amp;NR=H04225954A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IKEBE TSUGIO</creatorcontrib><creatorcontrib>MURAKAMI OSAMU</creatorcontrib><creatorcontrib>MORIMOTO YASUTO</creatorcontrib><creatorcontrib>TAKEHARA SHUZO</creatorcontrib><title>AMIDE COMPOUND, ITS PHARMACEUTICAL USE AND NEW 1-SUBSTITUTED PYRROLIDINEMETHYLAMINES</title><description>PURPOSE:To obtain a new amide compound useful for treating psychosomatic diseases and phrenopathy. CONSTITUTION:An amide compound expressed by formula I {R is 1-4C alkoxy; R is H or R and R are bonded to form oxyethylene; R is S(O)mR [R is 1-4C alkyl or phenylalkyl; (m) is 0-2] or SO2NR R (R and R are H or 1-4C alkyl); R is 6-15C alkyl} and its salt or optical isomer thereof, e.g. (S)-N-[(1- hexyl-2-pyrrolidinyl)methyl]2-methoxy-5-sulfamoylbenzamide. The af orementioned compound is obtained by reacting a carboxylic acid expressed by formula II or its reactive derivative with a 1-substituted pyrrolidine-2- methylamines expressed by formula III. The resultant compound is useful as an antischizophrenic agent, a therapeutic agent for dystropy, emotional disorder, etc., a medicine such as an inhibitor for psychosomatic diseases or emesis, a therapeutic agent for diarrhea originating from stress, tension of feeling, etc., and indefinite complaint of alimentary systems.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1992</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzL0KwjAUQOEsDqK-w3W3oLUdOsbkSiL5I7lBOpUicRIt1PdHBx_A6SwfZ8mIWy0RhLfBZyd3oClBUDxaLjCTFtxATgjcSXB4hUOV8imRpkwoIfQxeqOldmiRVG--N4dpzRb38TGXza8rtj0jCVWV6TWUeRpv5VnewyWofVPXbdc2_PiP-QBGJzCo</recordid><startdate>19920814</startdate><enddate>19920814</enddate><creator>IKEBE TSUGIO</creator><creator>MURAKAMI OSAMU</creator><creator>MORIMOTO YASUTO</creator><creator>TAKEHARA SHUZO</creator><scope>EVB</scope></search><sort><creationdate>19920814</creationdate><title>AMIDE COMPOUND, ITS PHARMACEUTICAL USE AND NEW 1-SUBSTITUTED PYRROLIDINEMETHYLAMINES</title><author>IKEBE TSUGIO ; MURAKAMI OSAMU ; MORIMOTO YASUTO ; TAKEHARA SHUZO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH04225954A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1992</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IKEBE TSUGIO</creatorcontrib><creatorcontrib>MURAKAMI OSAMU</creatorcontrib><creatorcontrib>MORIMOTO YASUTO</creatorcontrib><creatorcontrib>TAKEHARA SHUZO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IKEBE TSUGIO</au><au>MURAKAMI OSAMU</au><au>MORIMOTO YASUTO</au><au>TAKEHARA SHUZO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMIDE COMPOUND, ITS PHARMACEUTICAL USE AND NEW 1-SUBSTITUTED PYRROLIDINEMETHYLAMINES</title><date>1992-08-14</date><risdate>1992</risdate><abstract>PURPOSE:To obtain a new amide compound useful for treating psychosomatic diseases and phrenopathy. CONSTITUTION:An amide compound expressed by formula I {R is 1-4C alkoxy; R is H or R and R are bonded to form oxyethylene; R is S(O)mR [R is 1-4C alkyl or phenylalkyl; (m) is 0-2] or SO2NR R (R and R are H or 1-4C alkyl); R is 6-15C alkyl} and its salt or optical isomer thereof, e.g. (S)-N-[(1- hexyl-2-pyrrolidinyl)methyl]2-methoxy-5-sulfamoylbenzamide. The af orementioned compound is obtained by reacting a carboxylic acid expressed by formula II or its reactive derivative with a 1-substituted pyrrolidine-2- methylamines expressed by formula III. The resultant compound is useful as an antischizophrenic agent, a therapeutic agent for dystropy, emotional disorder, etc., a medicine such as an inhibitor for psychosomatic diseases or emesis, a therapeutic agent for diarrhea originating from stress, tension of feeling, etc., and indefinite complaint of alimentary systems.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPH04225954A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title AMIDE COMPOUND, ITS PHARMACEUTICAL USE AND NEW 1-SUBSTITUTED PYRROLIDINEMETHYLAMINES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A41%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IKEBE%20TSUGIO&rft.date=1992-08-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH04225954A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true